|
| 38057937 | The age-specific comorbidity burden of mild cognitive impairment: a US claims database study. | Alzheimers Res Ther | 2023 |
| 35897078 | Evaluation of tau deposition using <sup>18</sup>F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study. | Alzheimers Res Ther | 2022 |
| 37118137 | Designing the next-generation clinical care pathway for Alzheimer's disease. | Nat Aging | 2022 |
| 33971965 | Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach. | Alzheimers Res Ther | 2021 |
| 33773598 | Early detection of amyloid load using <sup>18</sup>F-florbetaben PET. | Alzheimers Res Ther | 2021 |
| 32929394 | Validation of a spatial normalization method using a principal component derived adaptive template for [<sup>18</sup>F]florbetaben PET. | Am J Nucl Med Mol Imaging | 2020 |
| 31858918 | Ecchordosis physaliphora: a cautionary tale. | J Laryngol Otol | 2020 |
| 31712324 | Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of <sup>18</sup>F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain. | J Nucl Med | 2020 |
| 31712323 | Tau PET imaging with <sup>18</sup>F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study. | J Nucl Med | 2020 |
| 31101517 | Comparison of <sup>18</sup>F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL<sup>®</sup> approaches: Validation against histopathology. | Alzheimers Dement | 2019 |
| 29140859 | Patient and Caregiver Assessment of the Benefits From the Clinical Use of Amyloid PET Imaging. | Alzheimer Dis Assoc Disord | 2018 |
| 29632177 | β-Amyloid accumulation in the human brain after one night of sleep deprivation. | Proc Natl Acad Sci U S A | 2018 |
| 29175981 | Validation of Noninvasive Tracer Kinetic Analysis of <sup>18</sup>F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol. | J Nucl Med | 2018 |
| 28643043 | <sup>18</sup>F-Florbetaben PET beta-amyloid binding expressed in Centiloids. | Eur J Nucl Med Mol Imaging | 2017 |
| 28183994 | Optimal Reference Region to Measure Longitudinal Amyloid-β Change with <sup>18</sup>F-Florbetaben PET. | J Nucl Med | 2017 |
| 28560157 | Optimized classification of <sup>18</sup>F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment. | Neuroimage Clin | 2017 |
| 27813444 | Advances in Aβ plaque detection and the value of knowing: overcoming challenges to improving patient outcomes in Alzheimer's disease. | Neurodegener Dis Manag | 2016 |
| 29067320 | Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development. | Alzheimers Dement (N Y) | 2016 |
| 25457431 | The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data. | Alzheimers Dement | 2015 |
| 26194317 | Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB). | Alzheimers Dement | 2015 |
| 25458309 | Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools? | Alzheimers Dement | 2014 |
| 23809366 | Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease. | Alzheimers Dement | 2013 |
| 21514691 | Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease. | Neurobiol Aging | 2012 |
| 23099060 | A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia. | Schizophr Res | 2012 |
| 22293721 | Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairment. | Anesthesiology | 2012 |
| 22343285 | Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. | Proc Natl Acad Sci U S A | 2012 |
| 21530003 | Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly. | Neurobiol Aging | 2012 |
| 20133017 | Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders. | Neurobiol Aging | 2011 |
| 27738359 | Rater Training for a Multi-Site, International Clinical Trial: What Mood Symptoms may be most Difficult to Rate? | Psychopharmacol Bull | 2011 |
| 21557720 | Errors in ADAS-cog administration and scoring may undermine clinical trials results. | Curr Alzheimer Res | 2011 |
| 21316814 | Structural brain changes in normal individuals with a maternal history of Alzheimer's. | Neurobiol Aging | 2011 |
| 20842159 | Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia. | J Cereb Blood Flow Metab | 2011 |
| 20197691 | Early detection of Alzheimer's disease with PET imaging. | Neurodegener Dis | 2010 |
| 27157481 | Evaluation of Early Dementia (Mild Cognitive Impairment). | PET Clin | 2010 |
| 20817151 | Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's. | Biol Psychiatry | 2010 |
| 20609722 | Does mild cognitive impairment increase the risk of developing postoperative cognitive dysfunction? | Am J Surg | 2010 |
| 20182025 | Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. | J Alzheimers Dis | 2010 |
| 20231448 | Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. | Proc Natl Acad Sci U S A | 2010 |
| 17889968 | Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. | Neurobiol Aging | 2009 |
| 20076796 | Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies. | J Clin Neurol | 2009 |
| 19661628 | Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology. | J Alzheimers Dis | 2009 |
| 19142633 | FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. | Eur J Nucl Med Mol Imaging | 2009 |
| 19221425 | Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease. | J Alzheimers Dis | 2009 |
| 19005175 | Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. | Neurology | 2009 |
| 18381771 | An entorhinal cortex sulcal pattern is associated with Alzheimer's disease. | Hum Brain Mapp | 2009 |
| 17920160 | The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease. | Neurobiol Aging | 2009 |
| 17222480 | Hippocampal hypometabolism predicts cognitive decline from normal aging. | Neurobiol Aging | 2008 |
| 18566819 | Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. | Eur J Nucl Med Mol Imaging | 2008 |
| 18590359 | Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. | Neuropsychology | 2008 |
| 18343551 | Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study. | Prog Neuropsychopharmacol Biol Psychiatry | 2008 |